BRUKER CORPORATION Increase (Decrease) in Accounts Payable
BRUKER CORPORATION (BRKR) reported Increase (Decrease) in Accounts Payable of -$37.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-02-27
- BRUKER CORPORATION increase (decrease) in accounts payable for the quarter ending 2012-06-30 was -$6.80M.
- BRUKER CORPORATION increase (decrease) in accounts payable for the quarter ending 2012-03-31 was $10.80M, a 24.48% decline year-over-year.
- BRUKER CORPORATION increase (decrease) in accounts payable for the quarter ending 2011-12-31 was -$2.40M.
- BRUKER CORPORATION increase (decrease) in accounts payable for the quarter ending 2011-09-30 was -$1.40M, a 193.33% decline year-over-year.
- BRUKER CORPORATION increase (decrease) in accounts payable for fiscal 2025 was -$37.50M, a 280.29% decline from fiscal 2024.
- BRUKER CORPORATION increase (decrease) in accounts payable for fiscal 2024 was $20.80M, a 1633.33% increase from fiscal 2023.
- BRUKER CORPORATION increase (decrease) in accounts payable for fiscal 2023 was $1.20M, a 96.40% decline from fiscal 2022.
- BRUKER CORPORATION increase (decrease) in accounts payable for fiscal 2022 was $33.30M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$37.50M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $20.80M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $1.20M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $33.30M 10-K · filed 2025-03-03 | |||
| 2012-06-30 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.00M 10-Q · filed 2012-08-09 | $1.60M derived: sum of 3 quarters · filed 2012-08-09 | $200.00K derived: sum of 4 quarters · filed 2012-08-09 |
| 2012-03-31 | $10.80M 10-Q · filed 2012-05-09 | $8.40M derived: sum of 2 quarters · filed 2012-05-09 | $7.00M derived: sum of 3 quarters · filed 2012-05-09 | $5.70M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$3.80M derived: sum of 2 quarters · filed 2012-02-29 | -$5.10M derived: sum of 3 quarters · filed 2012-08-09 | $9.20M 10-K · filed 2012-02-29 |
| 2011-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$2.70M derived: sum of 2 quarters · filed 2012-08-09 | $11.60M 10-Q · filed 2011-11-09 | $7.30M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $13.00M 10-Q · filed 2012-08-09 | $8.70M derived: sum of 3 quarters · filed 2012-08-09 | $10.20M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | $14.30M 10-Q · filed 2012-05-09 | $10.00M derived: sum of 2 quarters · filed 2012-05-09 | $11.50M derived: sum of 3 quarters · filed 2012-05-09 | $14.90M derived: sum of 4 quarters · filed 2012-05-09 |
| 2010-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$2.80M derived: sum of 2 quarters · filed 2012-02-29 | $600.00K derived: sum of 3 quarters · filed 2012-02-29 | $6.50M 10-K · filed 2012-02-29 |
| 2010-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $4.90M derived: sum of 2 quarters · filed 2011-11-09 | $10.80M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $9.30M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $5.90M 10-Q · filed 2011-05-09 | |||
| 2009-12-31 | $5.70M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |